Naropin

Nchi: Nyuzilandi

Lugha: Kiingereza

Chanzo: Medsafe (Medicines Safety Authority)

Viambatanisho vya kazi:

Ropivacaine hydrochloride monohydrate 5.29 mg/mL equivalent to 5 mg/mL Ropivacaine hydrochloride anhydrous;  

Inapatikana kutoka:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (Jina la Kimataifa):

Ropivacaine hydrochloride monohydrate 5.29 mg/mL (equiv to 5 mg/mL Ropivacaine hydrochloride anhydrous)

Kipimo:

5 mg/mL

Dawa fomu:

Solution for injection

Tungo:

Active: Ropivacaine hydrochloride monohydrate 5.29 mg/mL equivalent to 5 mg/mL Ropivacaine hydrochloride anhydrous   Excipient: Hydrochloric acid Sodium chloride Sodium hydroxide Water for injection

Vitengo katika mfuko:

Ampoule, plastic, polypropylene 5x10ml, 50 mL

Darasa:

Prescription

Dawa ya aina:

Prescription

Viwandani na:

BASF Pharma (Evionnaz) SA

Bidhaa muhtasari:

Package - Contents - Shelf Life: Ampoule, plastic, polypropylene 5x10ml - 50 mL - 36 months from date of manufacture stored at or below 30°C - Ampoule, plastic, polypropylene 5x20ml - 100 mL - 36 months from date of manufacture stored at or below 30°C

Idhini ya tarehe:

2000-04-17

Tabia za bidhaa

Naropin Data Sheet
NEW ZEALAND DATA SHEET
1. PRODUCT NAME
Naropin 2mg/mL Solution for Injection
Naropin 7.5mg/mL Solution for Injection
Naropin 10mg/mL Solution for Injection
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each mL of solution for injection contains 2mg, 7.5mg or 10mg of
ropivacaine hydrochloride.
For full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
N
AROPIN
solution for injection is a sterile, isotonic, isobaric, aqueous
solution.
Clear, colourless solution.
4. CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
N
AROPIN
is indicated for:
SURGICAL ANAESTHESIA
•
Epidural block for surgery, including Caesarean Section
•
Intrathecal block
•
Major nerve block
•
Field block (minor nerve block and infiltration)
ACUTE PAIN MANAGEMENT
•
Continuous epidural infusion (Naropin alone or in combination with
Fentanyl) or
intermittent bolus administration e.g. postoperative or labour pain
•
Field block (minor nerve block and infiltration)
•
Intra-articular injection
•
Continuous peripheral nerve block infusion or intermittent injections,
e.g. postoperative
pain management
•
Continuous wound infusion for postoperative pain management (adults
only)
ACUTE PAIN MANAGEMENT IN PAEDIATRICS (CHILDREN AGED 0 – 12 YEARS)
•
Caudal epidural block in neonates, infants and children up to and
including 12 years
•
Peripheral nerve block in children aged 1 up to and including 12 years
•
Continuous epidural infusion in neonates, infants and children up to
and including 12
years
For peri- and postoperative pain management.
4.2
DOSE AND METHOD OF ADMINISTRATION
N
AROPIN
should only be used by or under the supervision of clinicians
experienced in
regional anaesthesia.
Naropin Data Sheet
Copyright
2
ADULTS AND CHILDREN ABOVE 12 YEARS OF AGE:
The following table is a guide to dosage for the more commonly used
blocks. The clinician’s
experience and knowledge of the patient’s physical status are of
importance when deciding
the dose.
In general, surgical anaesthesia (e.g. epidural administration)
re